Sherry McKee
Yale University · Professor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
8
all conditions, ClinicalTrials.gov
NIH grants tied to them
20
1 more share only the name and are not shown
Trial papers
63
PubMed author-name match
Trials
Studies that name Sherry McKee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07029529 · Phase 2 Study of Apremilast in Women and Men With Alcohol Use DisorderYale University · recruiting · Alcohol Use Disorder · principal investigator
- N/ANCT06489782 · Developing a Novel Human Laboratory Paradigm for AUD Medication ScreeningYale University · recruiting · Alcohol Use Disorder · principal investigator
- Ph1NCT06324435 · Apremilast for Alcohol Use Disorder Treatment in Women and MenYale University · active not recruiting · Alcohol Use Disorder · principal investigator
- Ph2NCT04198116 · Combining Varenicline and Guanfacine for Smoking CessationYale University · completed · Smoking Cessation · principal investigator
- Ph2NCT03764098 · Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use DisordersYale University · recruiting · Alcohol Use · principal investigator
- Ph2NCT03588754 · Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?Yale University · suspended · Alcohol Drinking · principal investigator
- Ph2/Ph3NCT03539900 · Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating DisorderYale University · completed · Binge-Eating Disorder · principal investigator
- Ph2NCT02800928 · Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?Yale University · completed · Smoking · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Characterizing initial recovery from alcohol use disorder and predicting heavy drinking using mobile biosensorsR01AA031959 · NIAAA · YALE UNIVERSITY · fiscal years 2024 to 2026 · $683,215 awarded in 2026Same name and institution; not confirmed by an ID
- PROJECT 1: Phase 2a dose-response study of apremilast in females and males with alcohol use disorderU54AA027989 · NIAAA · YALE UNIVERSITY · fiscal years 2020 to 2026 · $250,001 awarded in 2026Grant number is on one of their registry trials
- Developing a novel human laboratory paradigm for AUD medication screening: Modeling the ability to resist drinking and heavy drinkingR34AA031678 · NIAAA · YALE UNIVERSITY · fiscal years 2024 to 2025 · $366,406 awarded in 2025Same name and institution; not confirmed by an ID
- Enhancing dissemination and career development in sex and gender translational science in alcohol useR13AA031402 · NIAAA · YALE UNIVERSITY · fiscal years 2023 to 2024 · $1 awarded in 2024Same name and institution; not confirmed by an ID
- Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and menR01DA047986 · NIDA · YALE UNIVERSITY · fiscal years 2020 to 2022 · $795,030 awarded in 2022Grant number is on one of their registry trials
- Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating DisorderR01DK112771 · NIDDK · YALE UNIVERSITY · fiscal years 2017 to 2021 · $683,698 awarded in 2021Grant number is on one of their registry trials
- Sex-Appropriate Treatment Development for Alcohol Use DisordersP01AA027473 · NIAAA · YALE UNIVERSITY · fiscal years 2018 to 2019 · $500,000 awarded in 2019Grant number is on one of their registry trials
- Admin-Core-001P50DA033945 · NIDA · YALE UNIVERSITY · fiscal years 2012 to 2017 · $57,898 awarded in 2017Grant number is on one of their registry trials
- Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?R01AA022285 · NIAAA · YALE UNIVERSITY · fiscal years 2014 to 2017 · $374,625 awarded in 2017Grant number is on one of their registry trials
- Phase-II Clinical Trial Evaluating Guanfacine for Smoking CessationR01DA035001 · NIDA · YALE UNIVERSITY · fiscal years 2013 to 2015 · $806,932 awarded in 2015Same name and institution; not confirmed by an ID
- Does doxazosin attenuate stress-induced smoking and improve clinical outcomes?R21DA033597 · NIDA · YALE UNIVERSITY · fiscal years 2012 to 2014 · $208,125 awarded in 2014Same name and institution; not confirmed by an ID
- Does Tobacco Legislation Reduce Alcohol Consumption?R21AA018273 · NIAAA · YALE UNIVERSITY · fiscal years 2010 to 2011 · $259,102 awarded in 2011Same name and institution; not confirmed by an ID
- Dose ranging study of varenicline on human alcohol self-administration behaviorR01AA017976 · NIAAA · YALE UNIVERSITY · fiscal years 2009 to 2011 · $320,053 awarded in 2011Same name and institution; not confirmed by an ID
- Modeling Stress-Precipitated Smoking Lapse for Medication Development (9 of 14)RL1DA024857 · NIDA · YALE UNIVERSITY · fiscal years 2007 to 2011 · $233,866 awarded in 2011Same name and institution; not confirmed by an ID
- Do Treatments for Smoking Cessation Reduce Alcohol Drinking?R01AA015596 · NIAAA · YALE UNIVERSITY · fiscal years 2006 to 2009 · $286,094 awarded in 2009Same name and institution; not confirmed by an ID
- MODELING SMOKING LAPSE BEHAVIOR FOR DRUG DEVELOPMENTP50AA015632 · NIAAA · YALE UNIVERSITY · fiscal years 2004 to 2008 · $202,743 awarded in 2008Same name and institution; not confirmed by an ID
- Investigating Tobacco & Alcohol Use Behaviors Across the Continuum of UseR03AA016267 · NIAAA · YALE UNIVERSITY · fiscal years 2005 to 2006 · $71,040 awarded in 2006Same name and institution; not confirmed by an ID
- Negative Affect and Smoking Behavior in Women and MenR21DA017234 · NIDA · YALE UNIVERSITY · fiscal years 2005 to 2006 · $210,326 awarded in 2006Same name and institution; not confirmed by an ID
- NICOTINE RECEPTOR ANTAGONIST ON SMOKING BEHAVIOR IN SCHIZOPHRENICSM01RR000125 · NCRR · YALE UNIVERSITY · fiscal years 2004 to 2005 · $4,852 awarded in 2005Same name and institution; not confirmed by an ID
- Alcohol Self-Administration/Effect/Nicotine ReplacementR03AA013622 · NIAAA · YALE UNIVERSITY · fiscal years 2002 to 2003 · $68,804 awarded in 2003Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:35 UTC. The ranking covers the 200 most relevant of 63 PubMed records, and a shared surname and initials can bring in a namesake. All 63 on PubMed
- Varenicline reduces alcohol self-administration in heavy-drinking smokers.Biol Psychiatry · 2009247 citationsRCR 8.2
- Stress decreases the ability to resist smoking and potentiates smoking intensity and reward.J Psychopharmacol · 2011229 citationsRCR 8.9
- Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA Psychiatry · 2025220 citationsRCR 67.8
- Modeling the effect of alcohol on smoking lapse behavior.Psychopharmacology (Berl) · 2006131 citationsRCR 4.6
- A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.Arch Intern Med · 200690 citationsRCR 3.2
- Message framing for smoking cessation: the interaction of risk perceptions and gender.Nicotine Tob Res · 200888 citationsRCR 3.1
- Contingency management for smoking cessation in adolescent smokers.Exp Clin Psychopharmacol · 200676 citationsRCR 2.7
- Risk factors for treatment failure in smokers: relationship to alcohol use and to lifetime history of an alcohol use disorder.Nicotine Tob Res · 200876 citationsRCR 2.8
- Developing and validating a human laboratory model to screen medications for smoking cessation.Nicotine Tob Res · 201272 citationsRCR 2.9
- Mood-induced increases in alcohol expectancy strength in internally motivated drinkers.Psychol Addict Behav · 200470 citationsRCR 2.7